Literature DB >> 24003252

Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.

Wanjin Hong1.   

Abstract

The Hippo pathway regulates cell proliferation and apoptosis during development, tissue regeneration, and carcinogenesis. Nuclear translocation of the transcription factors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) and their subsequent interaction with TEA domain (TEAD) transcriptional factors program pro-proliferative and antiapoptotic transcription. Scaffold proteins angiomotin (Amot) and angiomotin-related AmotL1 and AmotL2 were recently identified as negative regulators of YAP and TAZ by preventing their nuclear translocation. In this issue of Science Signaling, Yi et al. show that Amot may also promote nuclear translocation of YAP and act as a transcriptional cofactor of the YAP-TEAD complex to facilitate proliferation of biliary epithelial cells and cancer development of the liver either in response to tissue injury or in the absence of the tumor suppressor Merlin. These seemingly controversial results highlight that our understanding of Amot proteins in the Hippo pathway is so far limited.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24003252     DOI: 10.1126/scisignal.2004573

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  14 in total

1.  SMADs and YAP compete to control elongation of β-catenin:LEF-1-recruited RNAPII during hESC differentiation.

Authors:  Conchi Estarás; Chris Benner; Katherine A Jones
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

2.  Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.

Authors:  Zhipeng Xu; Jiamin Chen; Liming Shao; Wangqian Ma; Dingting Xu
Journal:  Tumour Biol       Date:  2015-05-15

Review 3.  Hippo-yap signaling in ocular development and disease.

Authors:  Matthew Lee; Navneet Goraya; Seonhee Kim; Seo-Hee Cho
Journal:  Dev Dyn       Date:  2018-04-23       Impact factor: 3.780

4.  Angiomotin regulates budding and spread of Ebola virus.

Authors:  Ziying Han; Gordon Ruthel; Shantoshini Dash; Corbett T Berry; Bruce D Freedman; Ronald N Harty; Olena Shtanko
Journal:  J Biol Chem       Date:  2020-05-07       Impact factor: 5.157

5.  AMOT130 linking F-actin to YAP is involved in intervertebral disc degeneration.

Authors:  Cong Zhang; Feng Wang; Zhiyang Xie; Lu Chen; Arjun Sinkemani; Haomin Yu; Xiaotao Wu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

Review 6.  The Angiomotins--from discovery to function.

Authors:  Susana Moleirinho; William Guerrant; Joseph L Kissil
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

7.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.

Authors:  Xiaodong Feng; Maria Sol Degese; Ramiro Iglesias-Bartolome; Jose P Vaque; Alfredo A Molinolo; Murilo Rodrigues; M Raza Zaidi; Bruce R Ksander; Glenn Merlino; Akrit Sodhi; Qianming Chen; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2014-05-29       Impact factor: 31.743

8.  Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish.

Authors:  Sobhika Agarwala; Sandra Duquesne; Kun Liu; Anton Boehm; Lin Grimm; Sandra Link; Sabine König; Stefan Eimer; Olaf Ronneberger; Virginie Lecaudey
Journal:  Elife       Date:  2015-09-03       Impact factor: 8.140

9.  Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy.

Authors:  Deborah Rotoli; Manuel Morales; Julio Ávila; María Del Carmen Maeso; María Del Pino García; Ali Mobasheri; Pablo Martín-Vasallo
Journal:  Int J Mol Sci       Date:  2017-04-22       Impact factor: 5.923

10.  siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice.

Authors:  Zhou Zhou; Jin-Shui Zhu; Cai-Ping Gao; Liang-Ping Li; Chao Zhou; Han Wang; Xiao-Gang Liu
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.